T-cell costimulation–biology, therapeutic potential, and challenges.
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The immune system has the remarkable ability to defend against diverse microbial pathogens and yet not to respond to self. T cells are key mediators of the immune response, and their activation is tightly regulated to prevent autoreactivity. The processes of T-cell activation and self-tolerance are therefore potential targets for manipulation by drugs — hence, the recent phase 1 trial of a “superagonistic” monoclonal anti-CD28 antibody that was conducted in Britain on behalf of the German firm TeGenero, with the unexpected and devastating results described by Suntharalingam et al. in this issue of the Journal (pages 1018–1028).T-cell activation requires . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“According to the currently accepted model of T cell activation, two signals are required to fully activate resting naïve T lymphocytes.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [2]
Citations
Cites
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Self-citationCytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Natural versus adaptive regulatory T cells
Bluestone, J. A., & Abbas, A. K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1032 · Cited by 1,323
Self-citationCTLA4Ig: Bridging the Basic Immunology with Clinical Application
Bluestone, J. A., St. Clair, E. W., & Turka, L. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.001 · Cited by 276
Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C.-H., Hanke, T., Hünig, T., Kerkau, T., & Gold, R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051060 · Cited by 203
CD28 superagonists: Mode of action and therapeutic potential
Hünig, T., & Dennehy, K. M. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.06.012 · Cited by 63
Drazen, J. M. (2006) · New England Journal of Medicine · doi:10.1056/nejme068175 · Cited by 13
Cited by
Items 101–200 of 203
Fang, C., Huang, Y., Pei, Y., Zhang, H., Chen, X., Guo, H., Li, S., Ji, X., & Hu, J. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1005-y · Cited by 23
High-Throughput Profiling of Ion Channel Activity in Primary Human Lymphocytes
Estes, D. J., Memarsadeghi, S., Lundy, S. K., Martí, F., Mikol, D. D., Fox, D. A., & Mayer, M. (2008) · Analytical Chemistry · doi:10.1021/ac800164v · Cited by 22
The Expression and Anatomical Distribution of BTLA and Its Ligand HVEM in Rheumatoid Synovium
Shang, Y., Guo, G., Cui, Q., Li, J., Ruan, Z., & Chen, Y. (2011) · Inflammation · doi:10.1007/s10753-011-9417-2 · Cited by 22
Antibody C Region Influences TGN1412-like Functional Activity In Vitro
Ball, C., Fox, B. J., Hufton, S. E., Sharp, G., Poole, S., Stebbings, R., Eastwood, D., Findlay, L., Parren, P. W. H. I., Thorpe, R., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201795 · Cited by 22
Xue, W., Yuan, X., Ji, Z. J., Li, H. L., & Yao, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1270920 · Cited by 21
Ralph, S. J. (2007) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200708030-00001 · Cited by 21
Contribution of PTPN22, CD28, CTLA-4 and ZAP-70 variants to the risk of type 1 diabetes in Tunisians
Zouidi, F., Stayoussef, M., Bouzid, D., Fourati, H., Abida, O., Ayed, M. B., Kammoun, T., Hachicha, M., Penha‐Gonçalves, C., & Masmoudi, H. (2013) · Gene · doi:10.1016/j.gene.2013.09.112 · Cited by 19
Trautmann, L., Said, E. A., Halwani, R., Janbazian, L., Chomont, N., Far, M. E., Breton, G., Haddad, E. K., & Sékaly, R. (2007) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3280ebb5c9 · Cited by 20
Sugarman, J., & Levine, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69881-4 · Cited by 19
Guo, G., Shang, Y., GuoYan, Z., Bao, X., Shiwei, X., & Chen, Y. (2011) · Clinical Rheumatology · doi:10.1007/s10067-011-1815-1 · Cited by 18
Paar, C., Wurm, S., Pfarr, W., Sonnleitner, A., & Wechselberger, C. (2007) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2007.03.001 · Cited by 18
Ohresser, M. C. P., Olive, D., Vanhove, B., & Watier, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69883-8 · Cited by 18
Basak, A. J., Maiti, S., Hansda, A., Mahata, D., Duraivelan, K., Kundapura, S. V., Lee, W., Mukherjee, G., De, S., & Samanta, D. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.09.013 · Cited by 17
Childhood allergy susceptibility: The role of the immune system development in the in-utero period
Zainal, N. H. M., Nor, N. H. M., Saat, A., & Clifton, V. L. (2022) · Human Immunology · doi:10.1016/j.humimm.2022.02.002 · Cited by 18
Pulmonary Administration: Strengthening the Value of Therapeutic Proximity
Videira, M., Llop, J., Sousa, C., Kreutzer, B., Cossío, U., Forbes, B., Vieira, I., Gil, N., & Lima, B. S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00050 · Cited by 18
Abul Abbas: An epitome of scholarship
Gershwin, M. E., & Shoenfeld, Y. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.07.006 · Cited by 16
Advances and challenges of CAR T therapy and suitability of animal models (Review)
Ramos-Cardona, X. E., Luo, W., & Mohammed, S. I. (2022) · Molecular and Clinical Oncology · doi:10.3892/mco.2022.2567 · Cited by 17
Diffusive transfer between two intensely interacting cells with limited surface kinetics
Labowsky, M. J., & Fahmy, T. M. (2012) · Chemical Engineering Science · doi:10.1016/j.ces.2012.02.001 · Cited by 16
Berrón‐Ruiz, L., López‐Herrera, G., Vargas‐Hernández, A., Santos‐Argumedo, L., López-Macías, C. I. R., Isibasi, A., Segura-Méndez, N. H., & Bonifaz, L. C. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.03.013 · Cited by 15
Sarkar, R., Mathew, A., & Sehrawat, S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900142 · Cited by 14
Cury, A. N., Longui, C. A., Kochi, C., Calliari, L. E., Scalissi, N. M., Salles, J. E. N., Rocha, M. N., de Melo, M. B., Melo, M. R., & Monte, O. (2008) · Hormone Research in Paediatrics · doi:10.1159/000129676 · Cited by 14
Drazen, J. M. (2006) · New England Journal of Medicine · doi:10.1056/nejme068175 · Cited by 13
Immunopathology and Immunomodulation
Metodiev, K. (2015) · InTech eBooks · doi:10.5772/59217 · Cited by 15
Can vitamin E and selenium alleviate the immunologic impact of aluminium on pregnant rats’ spleens?
Ayuob, N. N. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.07.019 · Cited by 12
Huang, W., Su, D., Xin, L., Yang, T., Lü, Y., & Zhang, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-27826-7 · Cited by 11
Update on Therapeutic Monoclonal Antibodies
Bussel, J. B., Giulino, L. B., Lee, S., Patel, V., Sandborg, C. I., & Stiehm, E. R. (2007) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2007.02.001 · Cited by 14
Penaloza‐MacMaster, P., Teigler, J. E., Obeng, R. C., Kang, Z. H., Provine, N. M., Parenteau, L. R., Blackmore, S., Ra, J., Borducchi, E. N., & Barouch, D. H. (2014) · Journal of Virology · doi:10.1128/jvi.00406-14 · Cited by 11
Said, R., Ye, Y., Hong, D. S., Naing, A., Falchook, G., Fu, S., Wheler, J. J., Piha-Paul, S. A., & Tsimberidou, A. M. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2952-z · Cited by 12
Bronchiolitis Obliterans after Combination Immunotherapy with Pembrolizumab and Ipilimumab
Balagani, A., Arain, M. H., & Sheshadri, A. (2018) · Journal of Immunotherapy and Precision Oncology · doi:10.4103/jipo.jipo_8_18 · Cited by 11
Development of Cancer Immunotherapies
DeLucia, D. C., & Lee, J. K. (2022) · Cancer treatment and research · doi:10.1007/978-3-030-96376-7_1 · Cited by 16
Harnessing the immune system for the treatment of melanoma: current status and future prospects
Guennoun, A., Sidahmed, H., Maccalli, C., Seliger, B., Marincola, F. M., & Bedognetti, D. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1176529 · Cited by 10
Pulmonary Toxicities of Immunotherapy
Altan, M., Zhong, L., Shannon, V. R., & Sheshadri, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-79308-1_14 · Cited by 11
Chen, Y., Aorigele, C., Wang, C., Hou, W., Zheng, Y., & Simujide, H. (2019) · Acta Veterinaria Brno · doi:10.2754/avb201988020233 · Cited by 10
Evolving Pharmacotherapies for the Treatment of Metastatic Melanoma
Salama, A. K. S. (2013) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s9565 · Cited by 10
Rudolf‐Oliveira, R. C. M., Auat, M., Cardoso, C. C., Santos‐Pirath, Í. M., Lange, B. G., da Silva, J. P., de Moraes, A. C. R., Dametto, G. C., Pirolli, M. M., Colombo, M. D. H. P., et al. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.12.007 · Cited by 9
Zhang, J., Cui, N., Long, Y., Wang, H., Han, W., Li, Y., & Xiao, M. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.10.028 · Cited by 9
Wise, M. P., Gallimore, A., & Godkin, A. J. (2006) · New England Journal of Medicine · doi:10.1056/nejmc062767 · Cited by 9
Hazra, R., Chattopadhyay, S., Mallick, A., Gayen, S., & Roy, S. (2024) · Medical Oncology · doi:10.1007/s12032-024-02416-3 · Cited by 8
Line, J., Thomson, P., & Naisbitt, D. J. (2022) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000834 · Cited by 8
Costimulation of Effector CD8+ T Cells: Which Receptor is Optimal for Immunotherapy?
Barber, A. (2014) · MOJ Immunology · doi:10.15406/moji.2014.01.00011 · Cited by 8
Recurrent Adrenergic Stress Provokes Persistent Myocarditis in PD-1–Deficient Mice
Hayashi, T., Lim, K. R. Q., Kovacs, A., & Mann, D. L. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2023.07.012 · Cited by 8
Moving Forward With Biologics in Lupus Nephritis
Hobeika, L., Ng, L., & Lee, I. J. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.08.008 · Cited by 9
Yang, X., Xu, F., Zhuang, C., Bai, C., Huang, W., Song, M., Han, Y., & Li, Y. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0678-3 · Cited by 7
Pharmacological Properties of Monoclonal Antibodies Directed Against Interleukins
Georgiev, K., & Georgieva, M. (2015) · InTech eBooks · doi:10.5772/61774 · Cited by 6
Said, R., Kakadiaris, E., Piha-Paul, S. A., Fu, S., Falchook, G. S., Jankú, F., Wheler, J. J., Zinner, R., Hong, D. S., Kurzrock, R., et al. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3000-3 · Cited by 7
Song, L., Ma, A., Dun, H., Hu, Y., Fujii, Y., Kinugasa, F., Oshima, S., Higashi, Y., Daloze, P., & Chen, H. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14039 · Cited by 7
The Role of Exhaustion in Tumor-Induced T-Cell Dysfunction in Cancer
Prado-García, H., & Romero‐Garcia, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_8 · Cited by 6
Tominaga, K., Toda, E., Takeuchi, K., Takakuma, S., Sakamoto, E., Kuno, H., Kajimoto, Y., Terasaki, Y., Kunugi, S., Mii, A., et al. (2024) · Pathology International · doi:10.1111/pin.13428 · Cited by 5
Cyclosporine Broadens the Therapeutic Potential of Lenalidomide in Myeloid Malignancies
Dou, A., & Fang, J. (2020) · Journal of Cellular Immunology · doi:10.33696/immunology.2.049 · Cited by 6
Lin, G., Yang, Y., Feng, Q., Zhan, F., Sun, C., Niu, Y., & Li, G. (2022) · Immunogenetics · doi:10.1007/s00251-021-01246-1 · Cited by 6
Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions
Sullivan, A. K., Watkinson, J., Waddington, J. C., Park, B. K., & Naisbitt, D. J. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1441285 · Cited by 4
[Tolerance and autoimmunity. Novel therapeutic approaches].
Ciliberti, E., Carambia, L., Cavallin, S., Cerda, O. L., Poderoso, J. J., & Rabinovich, G. A. (2009) · PubMed · Cited by 4
Stimulation of B7-H1 in Hepatocarcinoma Cells by Hepatitis B virus X Antigen
Wu, S., Yang, C., Guo, S. J., Fei, L., Luo, N., Fu, X., Chen, Y., & Wu, Y. (2010) · Immunological Investigations · doi:10.3109/08820139.2010.494193 · Cited by 4
Visich, J. E., & Ponce, R. A. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse199 · Cited by 4
Immunotherapy for precision medicine in colorectal cancer
Cao, M., Xu, M. Y., Bairmani, Z. A., Bashir, B., Waldman, S. A., & Snook, A. E. (2025) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2025.2560303 · Cited by 3
Cui, N., Wang, H., Long, Y., & Liu, D. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131095 · Cited by 3
Chen, Z., Liu, R., Che, J., Shi, H., Hou, Y., Liu, Y., Sun, L., Tan, L., Shan, C., Hu, P., et al. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2010.07.040 · Cited by 3
Immunmodulierende Antikörper in der Dermatoonkologie
Schrama, D., Hauschild, A., & Becker, J. C. (2008) · Der Hautarzt · doi:10.1007/s00105-008-1539-6 · Cited by 2
Effectiveness and Safety of Abatacept in Moderate to Severe Rheumatoid Arthritis
Cortejoso-Fernández, L., Romero-Jiménez, R. M., Pernía-López, M. S., Montoro, M., & Sanjurjo‐Sáez, M. (2011) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j36s3w · Cited by 2
Singla, A., & Kumar, S. K. (2011) · PubMed · Cited by 2
New aspects in the treatment of asthma: targeted therapy
Wang, Z. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200804010-00013 · Cited by 2
Ingulli, E. G., Alexander, S. I., & Briscoe, D. M. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_74 · Cited by 3
The Role of Exhaustion in Tumor-Induced T Cell Dysfunction in Cancer
Prado-García, H., Romero‐Garcia, S., & López-González, J. S. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_5 · Cited by 2
Bhagavan, N. V., & Ha, C.-E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-095461-2.00033-3 · Cited by 4
Dallman, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3343-1.50006-2 · Cited by 2
Rich, R. R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04404-2.10001-6 · Cited by 2
Rich, R. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3691-1.00025-8 · Cited by 2
Siegel, R. M., & Lipsky, P. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10015-4 · Cited by 2
Estimation of Human Starting Dose for Phase I Clinical Programs
Buckley, L. A., Garhyan, P., Ponce, R. A., & Roberts, S. (2010) · Wiley eBooks · doi:10.1002/9780470613191.ch10 · Cited by 2
Basic Science for the Clinician 46
Sigal, L. H. (2007) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318156d215 · Cited by 2
Targeting Immunological Synapse: New Horizons in Immunotherapy for Cancer
Chmielowski, B., & Ribas, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-087-8_48 · Cited by 1
The Immune Response to Transplanted Organs
Baldwin, W. M., Valujskikh, A., Lalli, P. N., & Fairchild, R. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-642-9_1 · Cited by 1
Development and Characterization of Experimental Autoimmune Cystitis (EAC)
İzgi, K. (2012) · EngagedScholarship @ Cleveland State University (Cleveland State University) · Cited by 2
Immunology of Pediatric Renal Transplantation
Ingulli, E. G., Alexander, S. I., & Briscoe, D. M. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_64 · Cited by 1
Immune Escape: Role of Indoleamine 2,3-Dioxygenase in Tumor Tolerance
Katz, J. B., Muller, A. J., Metz, R. A., & Prendergast, G. C. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0170-5_15 · Cited by 1
Immunológia újabb lehetőségei az onkológiai terápiában
Kiss, É. (2019) · Central European Journal of Gastroenterology and Hepatology · doi:10.33570/ceujgh.5.2.68 · Cited by 2
The Immunology of Transplantation
Castro‐Dopico, T., & Clatworthy, M. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53186-3.00002-4 · Cited by 1
Arzneimitteltestung am Menschen
Otte, A. (2007) · Der Internist · doi:10.1007/s00108-007-1798-9 · Cited by 1
Robertson, M. (2009) · Journal of Biology · doi:10.1186/jbiol175 · Cited by 1
Immune Profile and Signal Transduction of T-Cell Receptor in Autoimmune Thyroid Diseases
Cury, A. N. (2012) · InTech eBooks · doi:10.5772/35467
Truchetet, M., Richez, C., Contin‐Bordes, C., Blanco, P., Moreau, J., Bébéar, C., & Schaeverbeke, T. (2013) · Revue du Rhumatisme · doi:10.1016/j.rhum.2013.01.012
Molecular mechanisms in vascular inflammation
Olofsson, P. S. (2008) · Figshare
New Treatments and New Therapies
Barksdale, E. M., & Bobanga, I. (2016) · Springer eBooks · doi:10.1007/978-3-662-48590-3_37
Efficacy and Safety of Abatacept in Patients with Rheumatoid Arthritis: A Short-term Clinical Study
Mochizuki, T., & 茂樹, 桃. (2013) · Nihon Kansetsubyou Gakkaishi/Nihon Kansetsubyo Gakkaishi · doi:10.11551/jsjd.32.1
Redução das imunoglobulinas induzida pelo abatacepte não se associa com eventos infecciosos
Dinis, V. G. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-14122017-105648
Edwards, C. K., Pedler, M. G., Yang, D. F., Fitzpatrick, J. E., Fujita, M., Jonscher, K. R., & Norris, D. A. (2012) · Psoriasis Forum · doi:10.1177/247553031218a00304
Penn, S. K., & Moreland, L. W. (2009) · Elsevier eBooks · doi:10.1016/b978-032305475-1.50048-3
Ball, S. T., & Dallman, M. J. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4096-3.00002-7 · Cited by 1
Effects of Engineered Costimulation on the Function of T Cell Subsets
Boroughs, A. C. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Smedh, U., Gustafsson, A., Axelsson, H., Cahlin, C., Lönnroth, C., & Lundholm, K. (2010) · Springer eBooks · doi:10.1007/978-90-481-9531-2_15
Transcriptional Analysis of TH2 Primed Dendritic Cells and T cells
Morgan, C. (2021) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16850506.v1
Immunology of Pediatric Renal Transplantation
Ingulli, E. G., Alexander, S. I., & Briscoe, D. M. (2015) · Springer eBooks · doi:10.1007/978-3-642-27843-3_64-1
Singla, A., & Kumar, S. K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5260-7_8
Bhagavan, N. V., & Ha, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-416687-5.00033-6 · Cited by 1
Ha, C. E., & Bhagavan, N. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88541-6.00019-3
T-Cell Metabolism and Its Regulation by Checkpoint Molecules: Consequences for Cancer Immunotherapy
Romero‐Garcia, S., Mendoza, M. S., Carlos‐Reyes, Á., & Prado-García, H. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_159-1
Comparing how the microenvironments of the skin and lung shape T cell responses to vaccination
Palmer, O. R. (2020) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.22806971
Deciphering the Role of Immune-Checkpoint Inhibitors in Lung Cancer Treatment
Sharma, P., Singh, N., & Sharma, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-3746-2_19
T-Cell Metabolism and Its Regulation by Checkpoint Molecules: Consequences for Cancer Immunotherapy
Romero‐Garcia, S., Mendoza, M. S., Carlos‐Reyes, Á., & Prado-García, H. (2025) · Springer eBooks · doi:10.1007/978-3-032-00765-0_159
Metadata
- Authors
- Sharpe, A. H., & Abbas, A. K.
- Affiliations
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-09-07
- Volume
- 355
- Issue
- 10
- Pages
- 973-975
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2135741926
- Cited by
- 206
- References
- 7
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 4 · 2020: 9 · 2019: 10 · 2018: 15 · 2017: 10 · 2016: 11 · 2015: 12 · 2014: 8 · 2013: 14 · 2012: 17
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- T cell costimulation, T cell activation, self-tolerance, anti-CD28 monoclonal antibody, autoimmunity, T cell biology
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigen-Presenting Cells, Humans, Immune Tolerance, Lymphocyte Activation, T-Lymphocytes, Cytokines, CD28 Antigens, Models, Animal, Mice, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.